ADIAL PHARMACEUTICALS, INC. Cash And Cash Equivalents At Carrying Value

Quick Answer

ADIAL PHARMACEUTICALS, INC. reported Cash And Cash Equivalents At Carrying Value of $5.88 million for the year ending 2025.

  • ADIAL PHARMACEUTICALS, INC. showed an increase of +56.8% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
  • This data is from ADIAL PHARMACEUTICALS, INC.'s annual report (Form 10-K), filed with the SEC on March 5, 2026.
  • XBRL data for this metric is available from 2016 to 2025 (10 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 10 years of available data (2016 to 2025), ADIAL PHARMACEUTICALS, INC.'s Cash And Cash Equivalents At Carrying Value has grown by 6,583.7%.
  • Historical annual values: Fiscal year 2025: $5.88 million | Fiscal year 2024: $3.75 million | Fiscal year 2023: $2.83 million | Fiscal year 2022: $4.00 million | Fiscal year 2021: $6.06 million | Fiscal year 2020: $4.40 million | Fiscal year 2019: $6.78 million | Fiscal year 2018: $3.87 million | Fiscal year 2017: $18.2 thousand | Fiscal year 2016: $88.0 thousand.
  • Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: